Safety and Efficacy Study of DCVax-Direct in Solid Tumors
Ontology highlight
ABSTRACT: The study comprises a Phase I component during which the optimal dose of DCVax-Direct for the treatment of solid tissue tumors will be identified, followed by a Phase II component to determine if the injection of DCVax-Direct into selected solid tissue tumors has the ability to reduce tumor growth.
DISEASE(S): Melanoma,Colorectal Cancer,Liver Cancer,Pancreatic Cancer,Locally Advanced Tumor,Neoplasms,Metastatic Solid Tissue Tumors
PROVIDER: 2147052 | ecrin-mdr-crc |
REPOSITORIES: ECRIN MDR
ACCESS DATA